HIGHLIGHTS
- who: The Somatostatin Paradigm et al. from the Department University of Genova, Viale Benedetto XV, , Genova, Italy have published the paper: Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm, in the Journal: (JOURNAL)
- what: SST receptors represent a potential relevant drug_target for the treatment of several tumor histotypes.
- how: When translated to the clinical studies in patients with advanced colorectal cancer controversial results were obtained. To date contrasting or clearly negative results were obtained with the only significant exceptions of pituitary adenomas and possibly GEP-NETs.
- future: Studies are needed to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.